XANTHUS PHARMACEUTICALS, INC.
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 12, 2010 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 28 Total Citation Count
- Jul 08, 1991 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0204,263 METHOD OF TREATING MULTIDRUG RESISTANT CANCERSAbandonedJan 09, 08Aug 12, 10[A61K, A61P]
2010/0016,300 Imidazoacridine Compounds for Treating FLT3-Mediated DisordersAbandonedAug 02, 07Jan 21, 10[A61K, A61P]
2008/0108,641 Compounds for treating inflammatory disorders, demyelinating disdorders and cancersAbandonedAug 15, 07May 08, 08[A61K, C07D, A61P]
2006/0189,546 Compounds for treating autoimmune and demyelinating diseasesAbandonedJan 27, 06Aug 24, 06[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.